NCT04032821View on ClinicalTrials.gov

To Evaluate the Effect of Food on the Pharmacokinetic Characteristics of Alkotinib Capsules in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 20, 2019

Primary Completion Date

December 16, 2019

Study Completion Date

December 16, 2019

Conditions
NSCLC
Interventions
DRUG

Alkotinib（300mg)

1\. First empty stomach, after the meal.2. After eating first, after fasting.

Trial Locations (1)

130021

The first Bethune hospital of jilin university, Changchun

All Listed Sponsors
lead

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

INDUSTRY

NCT04032821 - To Evaluate the Effect of Food on the Pharmacokinetic Characteristics of Alkotinib Capsules in Healthy Subjects | Biotech Hunter | Biotech Hunter